Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.

2019-09-26 05:42:39 | BioPortfolio


The PRESTIGIO Registry is an Observational, prospective, multicentre study that includes patients, regularly followed by Italian Infectious Disease Centres, with HIV-1 infection and documented resistance to the 4 classes of antiretroviral drugs: nucleoside reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors (PI), and integrase inhibitors (INSTI).

Main objective of this register is to evaluate in the study population:

- the long-term effectiveness of different antiretroviral regimes;

- evolution of the genotype and phenotypic susceptibility of antiretroviral drugs used in patients with virological failure;

- mortality;

- incidence of opportunistic AIDS-related infections and chronic conditions (comorbidity);

- determinants of clinical outcomes including virological/immunological/inflammatory markers.

- antiretroviral therapy (ART) compliance and health assessments;

- drug-economy indications related to the clinical management of this complex sub-population.


The PRESTIGIO Register consists of a systematic and continuous collection of data on clinical, laboratory and treatment characteristics of patients with documented resistance to the 4 classes of antiretroviral drugs that meet the defined inclusion and exclusion criteria.

All the clinical centres of Infectious Diseases of the different Italian regions can participate in the implementation of the Registry. Based on an analysis conducted on data collected in an AIFA register, established for the purpose of monitoring the use of dolutegravir (DTG) 50 mg Bis in Die (BID) and containing about 200 patients with the criteria specified in this protocol, the size currently conceivable for this register in Italy is about 300 patients.

The collection of clinical information and biological samples will begin once the Ethics Committee of the participating centers has approved the participation in the registry and will continue for at least three years.

Study Design






Ospedale San Raffaele




Ospedale San Raffaele

Results (where available)

View Results


Published on BioPortfolio: 2019-09-26T05:42:39-0400

Clinical Trials [573 Associated Clinical Trials listed on BioPortfolio]

Chest Pain Unit II Register

Multicentric, prospective, non-interventional observational study with two parts: 1. A register of quality assurance within the recertification of clinics 2. An extended register wit...

Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs

Background The risk for hospitalized infection (i.e. infection leading to hospitalization) in patients with inflammatory arthritis (rheumatoid arthritis (RA), psoriatic arthritis (PsA) or ...

Transforming Physician Practice Through CREATION Health Study

The purpose of this study is to determine whether a standardized application of a physician-oriented CREATION Health curriculum is associated with reductions in burnout and perceived stres...

Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation

The purpose of this study is to investigate a promising strategy to improve maturation and patency rates following creation of AV fistulas and assess whether an anastomosis performed with ...

Comic Art Creation as Supportive Care in Cancer Patients and Caregivers

This pilot clinical trial studies how well comic art creation works as supportive care in cancer patients and caregivers. Participating in a comic art creation workshop may help patients a...

PubMed Articles [7024 Associated PubMed Articles listed on BioPortfolio]

Multiple sclerosis in Finland 2018- data from the national register.

Finland is a high-risk multiple sclerosis (MS) region, but a national MS register has not existed until 2014. In this paper we present the Finnish MS register variables and data collected by 31.12.201...

Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.

Millions of children are hospitalised due to respiratory syncytial virus (RSV) infection every year. Treatment is supportive, and current therapies (e.g. inhaled bronchodilators, epinephrine, nebulis...

Using a National Register as a Sampling Frame from the Perspective of an Early Career Researcher.

Selection of a sampling frame is a key component of conducting survey-based research. This article discusses the use of a national register, the Dental Register, as a sampling frame from the perspecti...

A national Transfusion Register of Irregular Antibodies and Cross (X)-match Problems: TRIX, a 10-year analysis.

The Transfusion Register of Irregular Antibodies and Cross-match Problems (TRIX) is a unique national database in the Netherlands that was launched in 2007. Transfusion laboratories register the prese...

The Swedish Neonatal Quality Register (SNQ) - contents, completeness and validity.

To describe the Swedish Neonatal Quality Register (SNQ) and to determine its completeness and agreement with other registers.

Medical and Biotech [MESH] Definitions

The creation of embryos specifically for research purposes.

Surgical creation of an opening in a cerebral ventricle.

Creation of an artificial external opening or fistula in the intestines.

Surgical creation of an opening (stoma) in the URINARY BLADDER for drainage.

Creation of a smooth and glossy surface finish on a denture or amalgam.

More From BioPortfolio on "Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease."

Quick Search

Relevant Topics

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...

Searches Linking to this Trial